Publications by authors named "James L. Pool"

Claim this Profile
C
Clinical role of direct renin inhibition in hypertension.
Addison A Taylor, James L Pool

Am J Ther· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of angiotensin receptor blockade on insulin sensitivity and endothelial function in abdominally obese hypertensive patients with impaired fasting glucose.
Todd S Perlstein, Robert R Henry, Kieren J Mather, Michael R Rickels, Nicola I Abate, James L Pool

Clin Sci (Lond)· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AJC Editor's consensus: Selective and nonselective nonsteroidal anti-inflammatory drugs and cardiovascular risk.
Vincent E Friedewald, Joel S Bennett, J Paul Christo, James L Pool, James M Scheiman

Am J Cardiol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of baseline blood pressure in guiding treatment choice: a secondary analysis of the use of valsartan/hydrochlorothiazide as initial therapy in hypertensive adults in a randomized, double-blind, placebo-controlled trial.
James L Pool, Robert Glazer, Nora Crikelair, Drew Levy

Clin Drug Investig· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Editor's Roundtable: Endothelial dysfunction in cardiovascular disease.
Vincent E Friedewald, Thomas D Giles, James L Pool, Clyde W Yancy, William C Roberts

Am J Cardiol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct renin inhibition: focus on aliskiren.
James L Pool

J Manag Care Pharm· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The editor's roundtable: concurrent hypertension and dyslipidemia.
Vincent E Friedewald, Peter H Jones, Norman M Kaplan, James L Pool, William C Roberts

Am J Cardiol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
James L Pool, Roland E Schmieder, Michel Azizi, Jean-Claude Aldigier, Andrzej Januszewicz

Am J Hypertens· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
James L Pool, Robert Glazer, Myron Weinberger, Roxanne Alvarado, Jie Huang

Clin Ther· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacology of antihypertensive therapy.
Addison A Taylor, James L Pool

Semin Nephrol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is it time to move to multidrug combinations?
James L Pool

Am J Hypertens· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Concepts of Pharmacotherapy in Hypertension - Alpha-Adrenergic Blocking Drugs: Evolving Role in Clinical Medicine.
Domenic A. Sica, James L. Pool

J Clin Hypertens (Greenwich)· March 2000

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis